RCT (n=465)
Open-label
Randomized
Hazard Ratio: 0.35 (95% CI 0.21–0.58)
Absolute Event Rate: 9% vs 22.9%
Absolute Risk Reduction: 14%
p-value: p=<0.001
A summary report of the 2013 European Society of Cardiology Congress highlighting key trials, updated guidelines, and the significant contribution of Japanese researchers.
The Annual Congress of the European Society of Cardiology (ESC) was held in Amsterdam from the 31(st) of August to the 4(th) of September 2013. The total attendance up to the 3(rd) was 29,990. Several important topics were presented and discussed, including a randomized trial of preventive angioplasty in myocardial infarction (PRAMI), transcatheter aortic valve implantation, renal denervation, management of vasospastic angina, plaque vulnerability and outcome assessed by OCT and diuretic resistance in heart failure (an ESC-JCS [Japanese Circulation Society] joint session), and OCT-guided percutaneous coronary intervention. The ESC congress has become one of the most important and attractive international scientific meetings. Importantly, Japan topped the number of abstracts submitted (1,459 abstracts) and accepted (565 abstracts) to ESC 2013. Thus, the ESC is eager to continue the strong collaboration with the JCS as the relationship between them gets closer year by year.
No takes yet. Share an insight, caveat, or question.
Yasuharu Matsumoto (2013) conducted an RCT in Myocardial Infarction with Multivessel Coronary Artery Disease (n=465). Preventive PCI vs. Culprit-only PCI was evaluated on Composite of cardiac death, nonfatal MI, or refractory angina (HR 0.35, 95% CI 0.21-0.58, p=<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: